Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
See Latest ArticlesDey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features
Mylan, 10/27/09
Dey Pharma, L.P., a subsidiary of Mylan Inc., launched a newly designed, patient–friendly EpiPen Auto–Injector 0.3/0.15 mg. This next–generation EpiPen Auto–Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto–Injector with several new, user–friendly features, including being the only auto–injector with needle–protection before and after use.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Receives FDA Approval for Generic Cardizem(R) LA
Watson Pharmaceuticals, 03/16/10
Boston Scientific Announces Ship Hold and Inventory Retrieval of ICD and CRT-D Devices
Boston Scientific, 03/16/10
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific's Novel Platinum Chromium TAXUS Element Stent System
Boston Scientific, 03/16/10
Article Search
Sponsor